Esophagus Cancer Clinical Trial
— SuperchargedOfficial title:
Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After Esophagectomy
NCT number | NCT05954702 |
Other study ID # | NP 1683 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 21, 2023 |
Est. completion date | October 2026 |
Esophagectomy has high rates of morbidity and mortality, in many cases due to esophagus reconstruction. Anastomotic leakage and fistula are the main esophagectomy complications. Many studies underwent to investigate the cause for anastomotic leakage after esophagectomy, however none of them conclude it is related to surgery or suture technique. However, it seems to be triggered by the ischemia caused after stomach mobilization to esophagus reconstruction, or even tension in the anastomosis. Considering the post esophagectomy with gastroplasty high morbidity and mortality rates, strategies to create a new vascularization source and decrease anastomotic leakage rates is important. In this study researchers will evaluate whether a TRAM flap transfer supercharged is effective on decrease morbidity related to anastomosis ischemia in patients undergoing esophagectomy.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | October 2026 |
Est. primary completion date | July 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Diagnosis of esophageal malignancy cancer; - Ability to understand and collaborate during treatment; Exclusion Criteria: - Previous gastrectomy; - Previous abdominal surgery with risk of altering stomach vascularization; - Previous head and neck surgery with risk of alteration of cervical vessels. |
Country | Name | City | State |
---|---|---|---|
Brazil | Instituto do Cancer do Estado de São Paulo (ICESP) | São Paulo | SP |
Lead Sponsor | Collaborator |
---|---|
Instituto do Cancer do Estado de São Paulo |
Brazil,
Akiyama H, Miyazono H, Tsurumaru M, Hashimoto C, Kawamura T. Use of the stomach as an esophageal substitute. Ann Surg. 1978 Nov;188(5):606-10. doi: 10.1097/00000658-197811000-00004. — View Citation
Akiyama H. Surgery for carcinoma of the esophagus. Curr Probl Surg. 1980 Feb;17(2):53-120. doi: 10.1016/s0011-3840(80)80025-6. No abstract available. — View Citation
Barzin A, Norton JA, Whyte R, Lee GK. Supercharged jejunum flap for total esophageal reconstruction: single-surgeon 3-year experience and outcomes analysis. Plast Reconstr Surg. 2011 Jan;127(1):173-180. doi: 10.1097/PRS.0b013e3181f95a36. — View Citation
Bourke MJ, Hope RL, Chu G, Gillespie PE, Bull C, O'Rourke I, Williams SJ. Laser palliation of inoperable malignant dysphagia: initial and at death. Gastrointest Endosc. 1996 Jan;43(1):29-32. doi: 10.1016/s0016-5107(96)70256-0. — View Citation
Briel JW, Tamhankar AP, Hagen JA, DeMeester SR, Johansson J, Choustoulakis E, Peters JH, Bremner CG, DeMeester TR. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg. 2004 Apr;198(4):536-41; discussion 541-2. doi: 10.1016/j.jamcollsurg.2003.11.026. — View Citation
Buskens CJ, Hulscher JB, Fockens P, Obertop H, van Lanschot JJ. Benign tracheo-neo-esophageal fistulas after subtotal esophagectomy. Ann Thorac Surg. 2001 Jul;72(1):221-4. doi: 10.1016/s0003-4975(01)02701-1. — View Citation
Collard JM, Tinton N, Malaise J, Romagnoli R, Otte JB, Kestens PJ. Esophageal replacement: gastric tube or whole stomach? Ann Thorac Surg. 1995 Aug;60(2):261-6; discussion 267. doi: 10.1016/0003-4975(95)00411-d. — View Citation
D'Amico TA, Harpole DH Jr. Molecular biology of esophageal cancer. Chest Surg Clin N Am. 2000 Aug;10(3):451-69. — View Citation
Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015 Jul 14;21(26):7933-43. doi: 10.3748/wjg.v21.i26.7933. — View Citation
Edsander-Nord A, Jurell G, Wickman M. Donor-site morbidity after pedicled or free TRAM flap surgery: a prospective and objective study. Plast Reconstr Surg. 1998 Oct;102(5):1508-16. doi: 10.1097/00006534-199810000-00025. — View Citation
El-Mrakby HH, Milner RH, McLean NR. Supercharged pedicled TRAM flap in breast reconstruction: is it a worthwhile procedure. Ann Plast Surg. 2002 Sep;49(3):252-7. doi: 10.1097/00000637-200209000-00003. — View Citation
Ferguson A, Kingstone K. Coeliac disease and malignancies. Acta Paediatr Suppl. 1996 May;412:78-81. doi: 10.1111/j.1651-2227.1996.tb14259.x. — View Citation
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9. — View Citation
Garcia-Vasquez C, Fernandez-Acenero MJ, Garcia Gomez-Heras S, Pastor C. Fibrin patch influences the expression of hypoxia-inducible factor-1alpha and nuclear factor-kappaBp65 factors on ischemic intestinal anastomosis. Exp Biol Med (Maywood). 2018 Jun;243(10):803-808. doi: 10.1177/1535370218777216. — View Citation
GARLOCK JH. Combined abdominothoracic approach for carcinoma of cardia and lower esophagus. Surg Gynecol Obstet. 1946 Dec;83(6):737-41. No abstract available. — View Citation
GARLOCK JH. Resection of thoracic esophagus for carcinoma located above arch of aorta; cervical esophagogastrostomy. Surgery. 1948 Jul;24(1):1-8. No abstract available. — View Citation
Garvey PB, Buchel EW, Pockaj BA, Casey WJ 3rd, Gray RJ, Hernandez JL, Samson TD. DIEP and pedicled TRAM flaps: a comparison of outcomes. Plast Reconstr Surg. 2006 May;117(6):1711-9; discussion 1720-1. doi: 10.1097/01.prs.0000210679.77449.7d. — View Citation
Goffi FS, Bevilacqua RG, Ferreira EA, Silva PA, Pinheiro Y, Lima EW, Bastos Eda S. [Surgery of cancer of he esophagus. Technic and results]. AMB Rev Assoc Med Bras. 1969 Jan;15(1):37-42. No abstract available. Portuguese. — View Citation
Griffin SM, Lamb PJ, Dresner SM, Richardson DL, Hayes N. Diagnosis and management of a mediastinal leak following radical oesophagectomy. Br J Surg. 2001 Oct;88(10):1346-51. doi: 10.1046/j.0007-1323.2001.01918.x. — View Citation
Grotting JC, Beckenstein MS, Arkoulakis NS. The art and science of autologous breast reconstruction. Breast J. 2003 Sep-Oct;9(5):350-60. doi: 10.1046/j.1524-4741.2003.09527.x. — View Citation
Harashina T, Sone K, Inoue T, Fukuzumi S, Enomoto K. Augmentation of circulation of pedicled transverse rectus abdominis musculocutaneous flaps by microvascular surgery. Br J Plast Surg. 1987 Jul;40(4):367-70. doi: 10.1016/0007-1226(87)90039-7. — View Citation
Hermreck AS, Crawford DG. The esophageal anastomotic leak. Am J Surg. 1976 Dec;132(6):794-8. doi: 10.1016/0002-9610(76)90461-x. — View Citation
Holmstrom H. The free abdominoplasty flap and its use in breast reconstruction. An experimental study and clinical case report. Scand J Plast Reconstr Surg. 1979;13(3):423-27. doi: 10.3109/02844317909013092. — View Citation
Kassis ES, Kosinski AS, Ross P Jr, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013 Dec;96(6):1919-26. doi: 10.1016/j.athoracsur.2013.07.119. Epub 2013 Sep 24. — View Citation
Kesler KA, Pillai ST, Birdas TJ, Rieger KM, Okereke IC, Ceppa D, Socas J, Starnes SL. "Supercharged" isoperistaltic colon interposition for long-segment esophageal reconstruction. Ann Thorac Surg. 2013 Apr;95(4):1162-8; discussion 1168-9. doi: 10.1016/j.athoracsur.2013.01.006. Epub 2013 Feb 21. — View Citation
Kim EK, Lee TJ, Eom JS. Comparison of fat necrosis between zone II and zone III in pedicled transverse rectus abdominis musculocutaneous flaps: a prospective study of 400 consecutive cases. Ann Plast Surg. 2007 Sep;59(3):256-9. doi: 10.1097/01.sap.0000252770.15946.14. — View Citation
Kim SH, Lee KS, Shim YM, Kim K, Yang PS, Kim TS. Esophageal resection: indications, techniques, and radiologic assessment. Radiographics. 2001 Sep-Oct;21(5):1119-37; discussion 1138-40. doi: 10.1148/radiographics.21.5.g01se031119. — View Citation
Koop H. Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy. 2004 Feb;36(2):103-9. doi: 10.1055/s-2004-814177. — View Citation
Kroll SS. Bilateral breast reconstruction in very thin patients with extended free TRAM flaps. Br J Plast Surg. 1998 Oct;51(7):535-7. doi: 10.1054/bjps.1998.0014. — View Citation
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825-31. doi: 10.1056/NEJM199903183401101. — View Citation
Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999 Jun 1;130(11):883-90. doi: 10.7326/0003-4819-130-11-199906010-00003. — View Citation
Liebermann-Meffert DM, Meier R, Siewert JR. Vascular anatomy of the gastric tube used for esophageal reconstruction. Ann Thorac Surg. 1992 Dec;54(6):1110-5. doi: 10.1016/0003-4975(92)90077-h. — View Citation
LONGMIRE WP Jr. A modification of the Roux technique for antethoracic esophageal reconstruction. Surgery. 1947 Jul;22(1):94-100. No abstract available. — View Citation
Marck KW, van der Biezen JJ, Dol JA. Internal mammary artery and vein supercharge in TRAM flap breast reconstruction. Microsurgery. 1996;17(7):371-4. doi: 10.1002/(SICI)1098-2752(1996)17:73.0.CO;2-J. — View Citation
Molina-Navarro C, Hosking SW, Hayward SJ, Flowerdew AD. Gastroaortic fistula as an early complication of esophagectomy. Ann Thorac Surg. 2001 Nov;72(5):1783-8. doi: 10.1016/s0003-4975(00)02569-8. — View Citation
Morris SF, Taylor GI. Predicting the survival of experimental skin flaps with a knowledge of the vascular architecture. Plast Reconstr Surg. 1993 Dec;92(7):1352-61. — View Citation
NAKAYAMA K. Statistical review of five-year survivals after surgery for carcinoma of the esophagus and cardiac portion of the stomach. Surgery. 1959 Jun;45(6):883-9. No abstract available. — View Citation
Pernia LR, Miller HL, Saltz R, Vasconez LO. "Supercharging" the rectus abdominis muscle to provide a single flap for cover of large mediastinal wound defects. Br J Plast Surg. 1991 May-Jun;44(4):243-6. doi: 10.1016/0007-1226(91)90064-q. — View Citation
Rezai M, Darsow M, Kummel S, Kramer S. Autologous and alloplastic breast reconstruction--overview of techniques, indications and results. Gynakol Geburtshilfliche Rundsch. 2008;48(2):68-75. doi: 10.1159/000118934. Epub 2008 Apr 16. — View Citation
Scheflan M, Hartrampf CR, Black PW. Breast reconstruction with a transverse abdominal island flap. Plast Reconstr Surg. 1982 May;69(5):908-9. No abstract available. — View Citation
Serletti JM. Breast reconstruction with the TRAM flap: pedicled and free. J Surg Oncol. 2006 Nov 1;94(6):532-7. doi: 10.1002/jso.20492. — View Citation
Urschel JD. Ischemic conditioning of the stomach may reduce the incidence of esophagogastric anastomotic leaks complicating esophagectomy: a hypothesis. Dis Esophagus. 1997 Jul;10(3):217-9. doi: 10.1093/dote/10.3.217. — View Citation
Valverde A, Hay JM, Fingerhut A, Elhadad A. Manual versus mechanical esophagogastric anastomosis after resection for carcinoma: a controlled trial. French Associations for Surgical Research. Surgery. 1996 Sep;120(3):476-83. doi: 10.1016/s0039-6060(96)80066-3. — View Citation
van Lanschot JJ, Hulscher JB, Buskens CJ, Tilanus HW, ten Kate FJ, Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer. 2001 Apr 15;91(8):1574-8. doi: 10.1002/1097-0142(20010415)91:83.0.co;2-2. — View Citation
Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001 Mar;233(3):338-44. doi: 10.1097/00000658-200103000-00006. — View Citation
Yamamoto Y, Nohira K, Sugihara T, Shintomi Y, Ohura T. Superiority of the microvascularly augmented flap: analysis of 50 transverse rectus abdominis myocutaneous flaps for breast reconstruction. Plast Reconstr Surg. 1996 Jan;97(1):79-83; discussion 84-5. doi: 10.1097/00006534-199601000-00013. — View Citation
* Note: There are 46 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence and number of post-operatory complications | surgical wound infection, hematoma, anastomotic leakage, stenosis, chylothorax and clinical complications due to hospitalization | Until 1 year after Surgery | |
Primary | Mortality | Patients who and when died | Until 1 year after surgery after surgery | |
Secondary | Days in intensive care unit | Number of days patient will stay at intensive care unit | From the surgery day until the date patient leave intensive care unit | |
Secondary | Hospitalization period | Number of days patient will stay in hospital after surgery | From the surgery day until the date patient leave hospital | |
Secondary | Need of vasoactive drugs | If patient use vasoactive drugs drugs hospitalization | From the surgery day until the date patient leave hospital | |
Secondary | Blood transfusion need | If patients need blood transfusion during hospitalization | From the surgery day until the date patient leave hospital | |
Secondary | Drain use time | How long patient use drain | From the surgery day until the date patient took off drain |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Completed |
NCT00201747 -
Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
|
Phase 2 | |
Recruiting |
NCT06036563 -
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
|
||
Not yet recruiting |
NCT05023928 -
Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer
|
Phase 1 | |
Recruiting |
NCT03941626 -
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
Recruiting |
NCT02988921 -
MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy
|
N/A | |
Completed |
NCT02979691 -
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
|
Phase 2/Phase 3 | |
Terminated |
NCT02797405 -
Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay
|
N/A | |
Recruiting |
NCT03347630 -
Pre-operative MRI of Esophagus Cancer
|
N/A | |
Completed |
NCT00193141 -
Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer
|
Phase 2 | |
Recruiting |
NCT05626309 -
Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer
|
N/A | |
Completed |
NCT05615129 -
Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
|
||
Recruiting |
NCT04821765 -
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
|
Phase 2 | |
Terminated |
NCT03108885 -
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
|
||
Recruiting |
NCT04046575 -
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
|
Phase 1 | |
Recruiting |
NCT06126406 -
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
|
Phase 1 | |
Completed |
NCT03467529 -
Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study
|
||
Completed |
NCT02552121 -
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT02001623 -
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
|
Phase 1/Phase 2 |